FDA warns Bristol's leukemia drug may raise lung risks | Reuters
Links shared publicly online about this topic.
- 0total visits
FDA warns Bristol's leukemia drug may raise lung risks | Reuters
(Reuters) - Health regulators warned on Tuesday that Bristol-Myers Squibb Co's leukemia drug Sprycel may raise the risk of a rare, but serious condition characterized by abnormally high blood pressure
View full resource at reuters.com
Tags: Leukemia, Leukemia Medication, Lung, Drug, Healthy Living, FDA, Bristol-Myers Squibb
Most Recently Shared on October 11, 2011 at 2:07 pm By:
FDA warns Bristol's leukemia drug may raise lung risks http://t.co/ftFuiCR9
Advertisement
